Journal of Hepatocellular Carcinoma

期刊简介：The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal. The journal provides the international community with a platform for the dissemination and study of clinical, translational, and basic research findings in this rapidly developing field. Primary liver tumors, primarily hepatocellular carcinoma (HCC), are the third leading cause of cancer death worldwide, with around 750,000 new cases annually, and around 700,000 deaths. While 80% occurs in the developing world, the incidence is beginning to decline due to hepatitis B vaccination and developments in food hygiene; conversely, there is an increasing incidence in the developed world, partly due to metabolic syndrome, obesity and diabetes. The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research. Meta-analyses will no longer be considered for publication. Specific topics covered by the journal include: cell signalling pathways molecular tumor classification and prognostication new drugs and other therapies new radiology approaches epidemiology, surveillance, and prevention psychosocial aspects and quality of life issues The journal will consider case reports only if they make a valuable and original contribution to the literature. Study protocols are not suitable unless at least pilot or baseline data are provided. When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors' own data through replication in an original sample.

【译文】《肝细胞癌杂志》是一本经过同行评审的国际开放获取期刊。该杂志为国际社会提供了一个传播和研究这一快速发展领域的临床、转化和基础研究成果的平台。原发性肝脏肿瘤，主要是肝细胞癌 (HCC)，是全球第三大癌症死亡原因，每年约有 750,000 个新病例，约 700,000 例死亡。虽然 80% 发生在发展中国家，但由于乙型肝炎疫苗接种和食品卫生的发展，发病率开始下降；相反，发达国家的发病率不断增加，部分原因是代谢综合征、肥胖和糖尿病。该杂志欢迎与 HCC 各个方面相关的原创研究手稿、评论、临床试验报告、专家意见和评论，涵盖从基础实验室研究到临床和转化研究。荟萃分析将不再考虑发表。该杂志涵盖的具体主题包括： 细胞信号传导途径 分子肿瘤分类和预测 新药物和其他疗法 新放射学方法 流行病学、监测和预防 心理社会方面和生活质量问题 只有对文献做出有价值和原创贡献的病例报告，该杂志才会考虑它们。除非至少提供试验数据或基线数据，否则研究方案是不合适的。在考虑提交利用公开数据的论文时，作者应确保此类研究能够显着丰富知识体系，并通过在原始样本中复制使用作者自己的数据进行验证。